vanoxerine has been researched along with kn 93 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blakely, RD; Bowton, E; Galli, A; Gill, M; Hamilton, PJ; Han, Q; Mazei-Robison, MS; Mergy, MA; Richtand, NW; Sakrikar, D; Veenstra-Vanderweele, J | 1 |
1 other study(ies) available for vanoxerine and kn 93
Article | Year |
---|---|
Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation.
Topics: Adolescent; Amphetamine; Analysis of Variance; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Benzylamines; Biotinylation; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Transformed; Child; Child, Preschool; Cholera Toxin; Cohort Studies; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Female; Humans; Immunoprecipitation; Luminescent Proteins; Male; Membrane Microdomains; Membrane Proteins; Piperazines; Polymorphism, Single Nucleotide; Protein Kinase Inhibitors; Protein Transport; Sulfonamides; Transfection; Tritium | 2012 |